期刊文献+

多囊卵巢综合征的心血管疾病风险 被引量:1

The Cardiovascular Risk of Polycystic Ovary Syndrome
下载PDF
导出
摘要 胰岛素抵抗、腹型肥胖、脂代谢紊乱、低度慢性炎症和高雄激素是多囊卵巢综合征(PCOS)的主要心血管危险因素,而其他因素如同型半胱氨酸、氧化应激、血栓形成等也可能增加心血管危险。而且,代谢综合征、2型糖尿病、高血压和阻塞性睡眠呼吸暂停等疾病在PCOS人群中更为常见,同样提示PCOS和心血管疾病间可能存在某种关系。然而,目前并无任何流行病学资料显示,PCOS人群比正常同龄人心血管疾病的发病率和死亡率更高。考虑到PCOS中高发的心血管危险因素,仍需对其远期风险给予重视并给予早期干预。 Insulin resistance, abdominal obesity, dyslipidemia, low-grade chronic inflammation and hyperandrogenism are thought to be the main cardiovascular risk factors in polycystic ovary syndrome (PCOS). Moreover, other factors, such as homocysteine, oxidative stress and thrombosis, probably contribute to their cardio- vascular risk profile. PCOS is also associated with increased risk of metabolic syndrome, type 2 diabetes, hyperten- sion and obstructive sleep apnea, which also suggest some possible link between PCOS and cardiovascular disease (CVD). There is no epidemiologicat evidence, however, showing that PCOS did not exhibit elevated morbility and mortality of CVD. Taking in consideration of the high risk of PCOS to develop future CVD, long term goals of therapy should focus on its prevention.
出处 《国际妇产科学杂志》 CAS 2009年第4期303-306,314,共5页 Journal of International Obstetrics and Gynecology
基金 国家自然科学基金(30672228)
关键词 多囊卵巢综合征 心血管疾病 胰岛素抵抗 肥胖 Polycystic ovary syndrome Cardiovascular disease Insulin resistance Obesity
  • 相关文献

参考文献20

  • 1Arikan S, Akay H, Bahceci M, et al. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function [J ]. Fertil Steril, 2009, 91 (2) :450--455. 被引量:1
  • 2Ketel I J, Stehouwer CD, Seme EH, et al. Obese but not normalweight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance [J ]. J Clin Endocrinol Metab, 2008, 93 (9) :3365-3372. 被引量:1
  • 3Puder JJ, Varga S, Kraenzlin M, et al. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance[J]. J Clin Endocrinol Metab, 2005, 90( 11 ): 6014-6021. 被引量:1
  • 4Cascella T, Palomba S, De Sio I, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome [J ]. Hum Reprod, 2008, 23( 1 ): 153-159. 被引量:1
  • 5Xita N, Papassotiriou I, Georgiou I, et al. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers [J ]. Metabolism, 2007, 56 (6): 766-771. 被引量:1
  • 6Carmina E, Chu MC, Moran C, et al. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome[J]. Fertil Steril, 2008, 89(3): 642-648. 被引量:1
  • 7Zwirska-Korczala K, Sodowski K, Konturek S J, et al. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome [J]. J Physiol Pharmacol, 2008, 59(Suppl 2): 161-178. 被引量:1
  • 8Valkenburg O, Steegers-Theunissen RP, Smedts HP, et al. A more atherogenic serum lipoprotein profile is present in women with polyeystic ovary syndrome: a case-control study [J]. J Clin Endocrinol Metab, 2008, 93 (2): 470-476. 被引量:1
  • 9Berneis K, Rizzo M, Hersberger M, et al. Atherogenic forms of dyslipidaemia in women with polyeystic ovary syndrome[J]. Int J Clin Praet, 2009, 63(1 ): 56-62. 被引量:1
  • 10Thomann R, Rossinelli N, Keller U, et al. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome [J ]. Gynecol Endocrinol, 2008, 24 (4): 199-206. 被引量:1

同被引文献29

  • 1DIAMANTI-KANDARAKIS E, CHRISTAKOU CD, KANDARAKI E, et al. Metformin : all old medication of new fashion: evolving newmolecular mechanisms and clinical implications in polyeystie ovary syndrome [J]. Eur J Endocrinol, 2010,162(2) : 193-212. 被引量:1
  • 2DOMECG JP, PRUTSKY G, MULLAN R J, et al. Adverse effects of the common treatments for polycystic ovary syndrome : a systematic review and meta-analysis [J]. J Clin Endocrinol Metab, 2013,98 (12) : 4646 - 4654. 被引量:1
  • 3CONWAY G, DEWAILLY D, DIAMANTI-KANDARAKIS E, et al. The polycystic ovary syndrome: a position statement from the European society of endocrinology [Jl. Eur J Endocrinol, 2014, 171 (4) : 1-29. 被引量:1
  • 4SANDSET PM. Mechanisms of hormonal therapy related thrombosis [ J ]. Thromb Res, 2013,131 ( 1 ) : 4-7. 被引量:1
  • 5MANZOLI L, DE VITO C, MARZUILLO C, et al. Oral contraceptives and venous thromboembolism: a systematic review and Meta-analysis [J]. Drug Saf, 2012,35(3) : 191-205. 被引量:1
  • 6STOCCO B, FUMAGALLI HF, FRANCESCHINI SA, et al. Comparative study of the effects of combined oral contraceptives in hemostatic variables:an Observational preliminary study [J ]. Medicine, 2015,94 (4) : e385. 被引量:1
  • 7TOULIS KA, GOULIS DG, MINTZIORI G, et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome [J]. Hum Reprod Update, 2011,17(6):741- 760. 被引量:1
  • 8CARMINA E. Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome [ J ]. Endocrinol Invest, 2013,36(5 ) : 358-363. 被引量:1
  • 9GLINTBORG D, SIDELMANN JJ, ALTINOK ML, et al. Increased Thrombin generation in women with polycystie ovary syndrome: A pilot study on the effect of mefforminand oral contraceptives [J ]. Metabolism, 2015,64(10) : 1272-1278. 被引量:1
  • 10BIRD ST, HARTZEMA AG, BROPHY JM, et al. Risk of venous thromboembolism in women with polycystie ovary syndrome: a population-based matched cohort analysis[J].CMAJ, 2013,185(2) :El15-E120. 被引量:1

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部